Maynard Um
-
-
-
-
-
-
-
New to The Street Show #760 Airs Tonight on Bloomberg Television Across the U.S. on Independence Day Featuring Sullivan & Cromwell’s Frank Aquila, Medicus Pharma, PetVivo, FreeCast and YY Group
-
-
-
-
-
-
-
Lantern Pharma announces roadmap for withZeta.ai AI platform expansion
-
-
-
-
-
-
-
RedChip Showcases Public Companies Driving Biotech Innovation at April 16 Virtual Investor Conference
-
-
-
-
-
-
-
Lantern Pharma Engages New to The Street for National Media Coverage Featuring Television, Press, Earned Media and Non-Deal Investor Focused Roadshows
-
-
-
-
-
-
-
FDA clears Starlight Therapeutics brain cancer trial for STAR-001 combo
-
-
-
-
-
-
-
Lantern Pharma (LTRN) Secures FDA Clearance for Planned Phase 1b/2 Trial of LP-184 in Biomarker-Defined, Treatment-Resistant NSCLC Patients with High Unmet Clinical Need
-
-
-
-
-
-
-
Lantern Pharma (LTRN) Announces Three U.S. FDA Rare Pediatric Disease Designations Granted to LP-184 in Multiple Ultra Rare Children’s Cancers
-
435,065 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

